A new drug could change everything for children like seven-year-old daughter, Liliana, who has Prader-Willi syndrome, a rare ...
The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...
Griffith-Atkins, a therapist and the parent of a child with Prader-Willi syndrome, invites fellow caregivers to acknowledge ...
Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...
Soleno's shares soar in the premarket hours following the FDA approval of Vykat XR (diazoxide choline) for treating hyperphagia in PWS patients.
Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to ...
The U.S. Food and Drug Administration approved Soleno Therapeutics' drug to treat a rare genetic disorder on Wednesday, ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic ...
The 17-year-old has grown up in the spotlight thanks to her famous parents' many TV projects over the years, with her birth ...
What are records? Since 2014, The Marshall Project has been curating some of the best criminal justice reporting from around the web. In these records you will find the most recent and the most ...
The youngster was diagnosed with Prader-Willi Syndrome as a baby, which means he never feels full, after showing signs of floppiness. His constant cravings first became a problem aged three when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results